-Beatrice H Hahn Researcher Activity Profile

Research Author Detailed Information 

Beatrice H Hahn Publication Rate By Year

Beatrice H Hahn has published 1 paper(s) in 2003, 1 paper(s) in 2006, 24 paper(s) in 2007, 2 paper(s) in 2008, for a total of 28 research publications in total.

Beatrice H Bh Hahn Author Information

LAST NAME: hahn

FIRST NAME: Beatrice H

INITIALS: bh

AFFILIATION:

Papers

Beatrice H Hahn's Publication Record

1. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. Year Published: 2006
Department of Surgery, Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, NC 27710, USA.
2. Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice. Year Published: 2007
Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1736, USA. kkahn@mednet.ucla.edu
3. The complexity of care for patients with rheumatoid arthritis: metrics for better understanding chronic disease care. Year Published: 2007
University of California at Los Angeles, Greater Los Angeles VA Healthcare System, Los Angeles, California 90095-1736, USA. kkahn@mednet.ucla.edu
4. Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins. Year Published: 2007
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
5. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Year Published: 2007
Division of Rheumatology, University of California-Los Angeles, 1000 Veteran Avenue, Los Angeles, CA 90095, USA.
6. Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. Year Published: 2007
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, Atlanta, GA 30329, USA.
7. CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression. Year Published: 2007
Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, 1001 Veteran Avenue, Los Angeles, CA 90095, USA.
8. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide. Year Published: 2007
David Geffen School of Medicine, University of California, Los Angeles, California, USA.
9. Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort. Year Published: 2007
University of California at Los Angeles, California 90095-1736, USA. kkahn@mednet.ucla.edu
10. Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees. Year Published: 2007
Department of Medicine, University of Alabama at Birmingham, 720 20th Street South, Kaul 816, Birmingham, AL 35294, USA.
11. Adaptation of HIV-1 to its human host. Year Published: 2007
Institute of Genetics, University of Nottingham, Queens Medical Centre, Nottingham, UK.
12. Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles. Year Published: 2007
Department of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, USA.
13. Gene vaccination for the induction of immune tolerance. Year Published: 2007
Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
14. Centralized HIV-1 envelope immunogens and neutralizing antibodies. Year Published: 2007
Duke Human Vaccine Institute, Duke University Medical Center, Durham NC 27710, USA. fgao@duke.edu
15. Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. Year Published: 2007
16. Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. Year Published: 2007
Institute of Virology, University of Ulm, Albert Einstein Allee 11, D-89081 Ulm, Germany.
17. Systemic lupus erythematosus: modern strategies for management - a moving target. Year Published: 2007
University of California, Los Angeles, USA.
18. Gene vaccination for the induction of immune tolerance. Year Published: 2007
Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
19. Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. Year Published: 2007
20. Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. Year Published: 2007
Institute of Virology, University of Ulm, Albert Einstein Allee 11, D-89081 Ulm, Germany.
21. Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles. Year Published: 2007
Department of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, USA.
22. Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome. Year Published: 2003
University of California at Los Angeles, 90095, USA.
23. pConsensus Peptide Induces Tolerogenic CD8+ T Cells in Lupus-Prone (NZB x NZW)F1 Mice by Differentially Regulating Foxp3 and PD1 Molecules. Year Published: 2008
Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
24. Centralized HIV-1 envelope immunogens and neutralizing antibodies. Year Published: 2007
Duke Human Vaccine Institute, Duke University Medical Center, Durham NC 27710, USA. fgao@duke.edu
25. Systemic lupus erythematosus: modern strategies for management: a moving target. Year Published: 2007
University of California Los Angeles, Division of Rheumatology, Rehab Center 32-59, Los Angeles, CA 90095, USA. jkking@mednet.ucla.edu
26. Centralized HIV-1 envelope immunogens and neutralizing antibodies. Year Published: 2007
Duke Human Vaccine Institute, Duke University Medical Center, Durham NC 27710, USA. fgao@duke.edu
27. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. Year Published: 2008
Department of Medicine, University of Alabama at Birmingham, 720 20th Street South, Kaul 816, Birmingham, AL 35294, USA.
28. Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins. Year Published: 2007
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.